Jane Street
MRTX

Jane Street’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Jane Street’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,200
Closed -$3.6M – 10432
2023
Q4 		$3.6M Buy
61,200
+47,300
+340% +$2.66M ﹤0.01% 3343
2023
Q3 		$605K Buy
13,900
+5,300
+62% +$189K ﹤0.01% 5988
2023
Q2 		$311K Buy
8,600
+2,900
+51% +$119K ﹤0.01% 7070
2023
Q1 		$212K Sell
5,700
-18,000
-76% -$810K ﹤0.01% 7762
2022
Q4 		$1.07M Sell
23,700
-40,500
-63% -$2.62M ﹤0.01% 4883
2022
Q3 		$4.48M Buy
64,200
+8,900
+16% +$659K ﹤0.01% 2790
2022
Q2 		$3.71M Sell
55,300
-18,000
-25% -$1.14M ﹤0.01% 3109
2022
Q1 		$6.03M Buy
73,300
+20,500
+39% +$2.1M ﹤0.01% 2722
2021
Q4 		$7.75M Buy
52,800
+14,700
+39% +$2.28M ﹤0.01% 2217
2021
Q3 		$6.74M Buy
38,100
+21,100
+124% +$3.39M ﹤0.01% 2316
2021
Q2 		$2.75M Buy
17,000
+400
+2% +$64.2K ﹤0.01% 3729
2021
Q1 		$2.84M Buy
16,600
+600
+4% +$119K ﹤0.01% 3361
2020
Q4 		$3.51M Buy
16,000
+2,000
+14% +$432K ﹤0.01% 2592
2020
Q3 		$2.33M Buy
14,000
+7,400
+112% +$1.01M ﹤0.01% 2809
2020
Q2 		$754K Buy
+6,600
New +$640K ﹤0.01% 4484

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's MRTX Position: Q1 2024 in Review

Jane Street sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 409,843 shares — an estimated $24.1M sold.

Jane Street first reported a position in MRTX in Q1 2014 and held it in 22 quarters. The position peaked at $24.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Jane Street reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 409,843 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.1M.
  • Jane Street first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2014 and held it in 22 quarters.
  • Jane Street's Mirati Therapeutics, Inc. Common Stock position peaked at $24.1M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.